AISAP, a Tel Aviv, Israel-based company providing an AI-powered point of care assisted diagnosis (POCAD)™ solution for the medical ultrasound industry, raised $13M in Seed funding.
The round was led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.
The company intends to use the funds to expand operations and development efforts.
Co-founded by Adiel Am-Shalom, Ehud Raanani, Robert Klempfner, Ehud Schwammenthal and led by CEO Roni Attali, AISAP provides a POCAD™ solution that offers AI-powered diagnoses including “urgency score” that enables medical providers to prioritize cases based on the severity of the condition, a score that measures the quality of the scan for operators, to ensure accuracy even if they are less familiar with traditional ultrasound devices, and Deep Learning AI capabilities that enable accurate readings even with lower-quality images from handheld machines. The solution can even provide diagnoses of specific valves within the cardiovascular systems.
AISAP’s algorithms have been trained on more than 300,000 studies comprising over 24 million video clips, and the technology has been validated by a range of medical experts from The Mayo Clinic, Inova Health Foundation, Jefferson Health, Poriya Institute and more.
FinSMEs
03/05/2024